REFERENCES
  1. Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A. Functional outcomes in elderly patients with hospitalized COVID-19 pneumonia: A 1 year follow-up study. Influenza and other respiratory viruses2022;16:1197-1198.
  2. Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022; 603: 700-705.
  3. Horita N, Fukumoto T. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic. J Med Virol. 2023; 95: e28231.
  4. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.Clin Microbiol Infect. 2020; 26: 1622-1629.
  5. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect.2020;81:266-275.
  6. Moreno-García E, Puerta-Alcalde P, Letona L, et al. Bacterial co-infection at hospital admission in patients with COVID-19.Int J Infect Dis. 2022;118:197–202.
  7. Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, Teramoto S, Kadota J, Tomono, K, Watanabe A. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation].Respir Investig . 2014;51:103-126.
  8. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index.Maryland State Med J. 1965;14:56-61.
  9. Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections. Guidelines for the management of community acquired pneumonia in adults, revised edition.Respirology 2006;11(Suppl 3): S79-133.